Skip to search formSkip to main contentSkip to account menu

BTO 956

Known as: BTO-956, BTO956 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Y-Doped BaTiO3 as a Charge-Trapping Layer for Nonvolatile Memory Applications
The charge-trapping properties of Y-doped BaTiO<sub>3</sub> (Y-BTO) are investigated using an Al/Al<sub>2</sub>O<sub>3</sub>/Y… 
2014
2014
Electrical characteristics of PVDF/BTO nanocomoposites under DC voltage application
The breakdown strength, conduction current, and space charge distribution were measured to understand the electrical… 
2011
2011
Barium Titanate-Based Magnetoelectric Nanocomposites
Barium Titanate (BaTiO3 or BTO) has attracted an ever increasing research interest because of its wide range of potential… 
2004
2004
THE TRUTH OF BTO アウトソーサーが提案する｢ビジネス革新｣は信用できるか : 新たなアウトソーシング･モデル : 「BTO」の可能性と課題 (OUTSOURCING ITアウトソーシング : その戦略的活用法を探る)
2001
2001
The novel tubulin-binding drug BTO-956 inhibits R3230AC mammary carcinoma growth and angiogenesis in Fischer 344 rats.
BTO-956 [methyl-3,5-diiodo-4-(4'-methoxyphenoxy)benzoate], a novel tubulin-binding drug and thyroid hormone analogue, was… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)